Summary In summary, we proposed that preparatory procedures for tissue procurement required for manufacturing an autologous cell-based immunotherapy or gene therapy be included in the payment of the product itself and that, beginning January 1, 2026, any preparatory procedures for tissue procurement required for manufacturing an autologous cell-based immunotherapy or gene therapy that were paid for by the manufacturer be included in the calculation of the manufacturer's ASP
#Japan #PMDA #IgANephropathy #DrugDevelopment #RegulatoryStrategy #ClinicalEndpoints #ConditionalApproval #LifeSciences To view or add a comment, sign in 884 followers
Of note, some of the MITF-dependent DEGs have previously been linked to apoptosis (Trpm1) and cell cycle progression ( Ccnd1 , Cdkn1a ) (Fig
The BP is considered a rich source of various vitamins, including B1, B2, and B6 (3, 59)
Temperature exposure outside the refrigeration range, such as during shipping delays or accidental freezing, can also damage the solution without visible cues